Title: TLR Xray structures
1TLR X-ray structures
- Harma Brondijk
- Bio-informatics course 2009
2TIR domain structures
- Protein-protein interaction surfaces
- Oligomerizationn interface
- Interaction surface(s) with TIR domains of
adapter molecules - MAL/MyD88
- TRAM/TRIF
- SARM
3TIR-domain structures
- TLR-TIR domains
- hTLR1 2.90 Å 1fyv (2000)
- hTLR2 3.00 Å 1fyw (2000)
- hTLR2-P681H 2.80 Å 1fyx (2000)
- hTLR2-C713S 3.20 Å 1o77 (2002)
- hTLR10 2.20 Å 2j67 (2006)
- Other TIR-domains
- hMyD88 (NMR) 2js7/2z5v (2008)
- IL1RAPL 2.30 Å 1t3g (2005)
4TIR domains similar structure, flexible regions
hTLR1
hTLR2
hTLR2_P681H
hTLR10
IL1RAPL
hTLR2_C713S
5TIR domains similar structure, flexible regions
BB-loop
6Dimer interfaces which is the true interface?
hTLR1 - 1 molecule in the asymetric unit -
protein-protein contacts -gt two possible dimer
interfaces
hTLR1 807 Å2, 2 saltbridges
hTLR1 725 Å2, 2 disulfide
7Dimer interfaces which is the true interface?
hTLR1
hTLR10
hTLR2
hTLR2-P681H
hTLR2-C713S
8TLR1-TLR2 TIR domain docking putative dimer
GAUTAM et al. JBC 2006
9hTLR10 TIR dimer most likely real signaling
dimer
Molecule B
Molecule A
Nyman et al. JBC 2008
10Conserved surface patches possible interaction
surfaces
In general surface residues are much less
conserved than core residues Interaction surfaces
need to change concerted in both interaction
partners -gt Interaction surfaces are relatively
higly conserved
Xu et al. Nature 2000
11Modelling Information driven docking programs
-gt Putative TLR4-Mal/TRAM interactions
Miguel et al. PLoS ONE 2007
12LRR domain structures
- Issues
- Overall structure
- Interaction with ligands (agonist/antagonist)
- Ligand induced dimerization?
- Conformational changes
- Interfaces
- Interactions with co-factors
13LRR-domain structures
- TLR ectodomains
- hTLR1/hTLR2 dimer PAM3CSK4 (TLR1 aa 25-475/TLR2
aa 27-506) - 2.10 Å 2z7x (2007)
- hTLR2 aa 1-284 1.80 Å 2z80 (2007)
- mTLR2 aa 27-506 1.80 Å/2.60 Å 2z81/2z82 (2007)
- hTLR3 2.10 Å 1ziw (2005)
- hTLR3 2.40 Å 1aoz (2005)
- mTLR3 2.66 Å 3cig (2008)
- mTLR3 dsRNA 3.41 Å 3ciy (2008)
- hTLR4 aa27-228 1.70 Å 2z62 (2007)
- hTLR4 aa 27-527 2.00 Å 2z63 (2007)
- hTLR4/MD2/Eritoran 2.70 Å 2z65 (2007)
- - hTLR4/MD2/LPS 3.10 Å 3FXI (2009)
- mTLR4/MD2 2.84 Å 2z64 (2007)
- CD14 2.50 Å 1wwl (2005)
14TLR ecto-domains consist ofleucine-rich-repeats
hTLR3
hTLR3
Choe et al. Science 2005 Bell et al. PNAS 2005
Curvature may vary along the ectodomain
TLR1/2/4 divided in 3 distinct regions
15LRR domain architecture
- LRR
- 20-30 residues (extensions possible)
- defining motif
- LxxLxLxxNxL
- LLeu/Val/Ile/Phe
- NAsn/Thr/Ser/Cys
- Repeat -gt curved solenoid structure
- Concave side continuous parallel ß-sheet
- Convex side variable
- Cavity of solenoid structure filled with
hydrophobic residues
16The Leucine-rich repeat structure diversity
rules!
Always ß-sheet on concave side, convex side
varaible
Polyproline II helix
a-helix
Extensions possible on convex and lateral sides
(examples from TLR3 structure)
310-helix
2 Polyproline II helices
Other combinations of helices and strands
17Ligand binding TLRs recognize chemically diverse
compounds
18How do TLRs recognize/bind their ligands?
How does ligand binding induce TLR
oligomerization?
19mTLR3-dsRNA complex
2 TLR3 molecules bind adjacently to the dsRNA
C-termini 25 Å apart
Liu et al. Science, 2008
20dsRNA-mTRL3 interactions
N
C
- Two interaction sites close to N and C terminus
- Interactions with sugar-phosphate backbones only
explains lack of sequence specificity - Histidine involvement explains pH dependence
N
C
Liu et al. Science, 2008
21mTRL3-mTLR3 interactions
- Direct TLR3-TLR3 contacts near C-terminal
interaction site explains concerted binding
C
N
N
C
Liu et al. Science, 2008
22hTLR1-hTLR2 Pam3CSK4 complex
C-termini lt42 Å apart
Jin et al. Cell 2007
23hTLR1-hTLR2 Pam3CSK4 complex
Ligand binds to both TLR1 and TLR2 -gt
heterodimerization
Top view
Question How does the hTLR2-hTLR6 dimer form??
(ligand lacks the 3rd lipid chain)
Jin et al. Cell 2007
24mTLR4-mMD2 complex
MD2 binds on the edge of the central and
N-terminal region, at the lateral side of the
molecule
Kim et al. Cell 2007
25hTLR4/VLR-hMD2 Eritoran
Kim et al. Cell 2007
26hTLR4-MD2-LPS homodimer
Park et al. Nature 2009
27Dimerization through LPS and MD2 interactions
MD2
TLR4
MD2
TLR4
28What makes LPS an agonist?
Lipid Iva and Eritoran have fewer lipid tails -gt
bind deeper in the MD2 binding pocket -gt
Phosphates not available for interactions
Park et al. Nature 2009
29TLR4 dimerization appears to induce a
conformational change
Central domains of TLR1/2/4 less rigid compared
to standard LRR structures needed to accommodate
conformational changes???
Park et al. Nature 2009
30Central theme ligand interactions induce
dimerization -gt C-termini in close approximation
Park et al. Nature 2009
31Thanks for your attention
32Dimerization through LPS and MD2 interactions
33TLR4-MD2-LPS dimerization interactions
34TIR domain plasticity
TLR2-TLR2 comparison
TLR1-TLR2 comparison
Xu et al. Nature 2000
Tao et al. BBRC 2002